FDA Updates Part 11 Guidance to Include Mobile Tech, Wearables

International Pharmaceutical Regulatory Monitor
A A
The FDA has released a new draft guidance that clarifies the Part 11 regulations for electronic records and signatures as they apply to clinical trials, including validation of mobile and wearable technology and the use of outsourcing and contracting.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor